Correction: Onodera et al. Prognostic Factors and Talaporfin Sodium Concentration in Photodynamic Therapy for Recurrent Grade 4 Glioma. Pharmaceuticals 2025, 18, 583

Authors

Institutions

Publication Details

Journal
Pharmaceuticals
Published
2025-10-21
DOI
https://doi.org/10.3390/ph18101586
Primary Topic
Nanoplatforms for cancer theranostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Correction: Onodera et al. Prognostic Factors and Talaporfin Sodium Concentration in Photodynamic Therapy for Recurrent Grade 4 Glioma. Pharmaceuticals 2025, 18, 583

Mikoto Onodera, Yasuto Sato, Takakazu Kawamata, Yoshihiro Muragaki et al.
Pharmaceuticals
Nanoplatforms for cancer theranostics
article

Correction: Onodera et al. Prognostic Factors and Talaporfin Sodium Concentration in Photodynamic Therapy for Recurrent Grade 4 Glioma. Pharmaceuticals 2025, 18, 583

Mikoto Onodera, Yasuto Sato, Takakazu Kawamata, Yoshihiro Muragaki, Shuji Kitahara, Ken Masamune
article en

Abstract

No abstract available for this paper.
PharmaceuticalsVol. 18(10)
University of Shizuoka (JP), Tokyo Women's Medical University (JP), Kobe University (JP)
Openalex Percentile: Top 71%
Nanoplatforms for cancer theranostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.